GU ASCO annual meeting featured a urothelial carcinoma session and a presentation by Dr. Nataliya Mar discussing real world toxicity profile of enfortumab vedotin with or without pembrolizumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback